iRhythm Holdings Financials - Benzinga

iRhythm Holdings Inc

IRTCNASDAQ

Trade with Public

Trade with Public

$111.82

-0.06-0.05%

At close: Sep 16, 5:00 PM EST

$111.82

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

iRhythm Holdings Financials

iRhythm Holdings (IRTC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care

iRhythm to acquire VitalConnect for $287.5 million, expands cardiac monitoring portfolio after Q2 earnings beat and higher fiscal 2026 guidance.

Vandana Singh

PRO
iRhythm Holdings Raises FY2026 Sales Guidance from $875.000M-$885.000M to $880.000M-$890.000M vs $881.129M Est

iRhythm Holdings (NASDAQ:IRTC) raises FY2026 sales outlook from $875.000 million-$885.000 million to $880.000 million-$890.000 million vs $881.129 million estimate.

Benzinga Newsdesk

PRO
iRhythm Technologies Q2 Adj. EPS $0.58 Beats $(0.00) Estimate, Sales $224.172M Beat $219.324M Estimate

iRhythm Technologies (NASDAQ:IRTC) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $(0.00) by Infinity percent. This is a 281.25 percent increase over losses of $(0.32) per

Benzinga Newsdesk

PRO
iRhythm Holdings Raises FY2026 Sales Guidance from $870.000M-$880.000M to $875.000M-$885.000M vs $876.068M Est

iRhythm Holdings (NASDAQ:IRTC) raises FY2026 sales outlook from $870.000 million-$880.000 million to $875.000 million-$885.000 million vs $876.068 million estimate.

Benzinga Newsdesk

PRO
iRhythm Technologies Q1 Adj. EPS $(0.35) Beats $(0.65) Estimate, Sales $199.390M Beat $194.027M Estimate

iRhythm Technologies (NASDAQ:IRTC) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.65) by 46.15 percent. This is a 63.16 percent increase over losses of $(0.95) per share

Benzinga Newsdesk

Earnings Scheduled For April 30, 2026

Benzinga Insights